Infliximab | Placebo | |||||||
---|---|---|---|---|---|---|---|---|
Day 0 | Day 70 | Δ day 70–day 0 | P a | Day 0 | Day 70 | Δ day 70–day 0 | P a | |
Fasting glucose (mmol/L) | 5.7 ± 0.4 | 5.4 ± 0.3 | −0.1 ± 0.1 | nsb | 5.4 ± 0.2 | 5.4 ± 0.2 | −0 ± 0.1 | ns |
Fasting insulin (µU/L) | 15.9 ± 3.5 | 15.9 ± 4.2 | −0.9 ± 4 | ns | 15.2 ± 2.7 | 13.9 ± 3.3 | 0.4 ± 1.6 | ns |
HOMA index | 4.2 ± 1.2 | 3.8 ± 1.0 | −0.2 ± 0.9 | ns | 3.7 ± 0.8 | 3.4 ± 0.8 | 0.1 ± 0.4 | ns |
Insulin sensitivity index (10−4 min−1(µU/mL)−1) | 2.2 ± 0.4 | 1.8 ± 0.4 | −0.4 ± 0.1 | 0.049 | 1.8 ± 0.5 | 1.8 ± 0.5 | 0.1 ± 0.2 | ns |